Arkolith/Insider Trading/FSTX/Form 4

Kayitalire Louis

Chief Medical OfficerF-star Therapeutics, Inc. (FSTX) · full profile →Form 4 · filed Nov 4, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$437
Net Open-Market Flow
-$437
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 2, 2021Sell(S)25$6.85$17154K
Nov 2, 2021Sell(S)39$6.81$26654K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-063046) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML